Williams LW - Search Results

1

Cost-effectiveness of donepezil in the treatment of mild or moderate Alzheimer's disease.

Neumann PJ, Hermann RC, Kuntz KM, Araki SS, Duff SB, Leon J, Berenbaum PA, Goldman PA, Williams LW, Weinstein MC. Neumann PJ, et al. Among authors: williams lw. Neurology. 1999 Apr 12;52(6):1138-45. doi: 10.1212/wnl.52.6.1138. Neurology. 1999. PMID: 10214734

2

Cost-effectiveness of HMG-CoA reductase inhibition for primary and secondary prevention of coronary heart disease.

Goldman L, Weinstein MC, Goldman PA, Williams LW. Goldman L, et al. Among authors: williams lw. JAMA. 1991 Mar 6;265(9):1145-51. JAMA. 1991. PMID: 1899896

3

Cost-effectiveness of cholesterol-lowering therapies according to selected patient characteristics.

Prosser LA, Stinnett AA, Goldman PA, Williams LW, Hunink MG, Goldman L, Weinstein MC. Prosser LA, et al. Among authors: williams lw. Ann Intern Med. 2000 May 16;132(10):769-79. doi: 10.7326/0003-4819-132-10-200005160-00002. Ann Intern Med. 2000. PMID: 10819699

4

Cost effectiveness of aspirin, clopidogrel, or both for secondary prevention of coronary heart disease.

Gaspoz JM, Coxson PG, Goldman PA, Williams LW, Kuntz KM, Hunink MG, Goldman L. Gaspoz JM, et al. Among authors: williams lw. N Engl J Med. 2002 Jun 6;346(23):1800-6. doi: 10.1056/NEJM200206063462309. N Engl J Med. 2002. PMID: 12050341 Free article.

5

Long-term cost-effectiveness of various initial monotherapies for mild to moderate hypertension.

Edelson JT, Weinstein MC, Tosteson AN, Williams L, Lee TH, Goldman L. Edelson JT, et al. JAMA. 1990 Jan 19;263(3):407-13. JAMA. 1990. PMID: 2136759

6

Cost-effectiveness of vitamin therapy to lower plasma homocysteine levels for the prevention of coronary heart disease: effect of grain fortification and beyond.

Tice JA, Ross E, Coxson PG, Rosenberg I, Weinstein MC, Hunink MG, Goldman PA, Williams L, Goldman L. Tice JA, et al. JAMA. 2001 Aug 22-29;286(8):936-43. doi: 10.1001/jama.286.8.936. JAMA. 2001. PMID: 11509058

7

The effect of risk factor reductions between 1981 and 1990 on coronary heart disease incidence, prevalence, mortality and cost.

Goldman L, Phillips KA, Coxson P, Goldman PA, Williams L, Hunink MG, Weinstein MC. Goldman L, et al. J Am Coll Cardiol. 2001 Oct;38(4):1012-7. doi: 10.1016/s0735-1097(01)01512-1. J Am Coll Cardiol. 2001. PMID: 11583874 Free article.

8

Cost-effectiveness considerations in the treatment of heterozygous familial hypercholesterolemia with medications.

Goldman L, Goldman PA, Williams LW, Weinstein MC. Goldman L, et al. Among authors: williams lw. Am J Cardiol. 1993 Sep 30;72(10):75D-79D. doi: 10.1016/0002-9149(93)90015-5. Am J Cardiol. 1993. PMID: 8213502

9

Cost-effectiveness of populationwide educational approaches to reduce serum cholesterol levels.

Tosteson AN, Weinstein MC, Hunink MG, Mittleman MA, Williams LW, Goldman PA, Goldman L. Tosteson AN, et al. Among authors: williams lw. Circulation. 1997 Jan 7;95(1):24-30. doi: 10.1161/01.cir.95.1.24. Circulation. 1997. PMID: 8994412

10

Relative impact of targeted versus populationwide cholesterol interventions on the incidence of coronary heart disease. Projections of the Coronary Heart Disease Policy Model.

Goldman L, Weinstein MC, Williams LW. Goldman L, et al. Among authors: williams lw. Circulation. 1989 Aug;80(2):254-60. doi: 10.1161/01.cir.80.2.254. Circulation. 1989. PMID: 2787708

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

87 results

Search Page

Filters